US FDA Never Fully Enforced The Clozapine REMS. Now’s It’s Not Needed

The Risk Evaluation and Mitigation Strategy hindered access and burdened the health care system even though it was never fully implemented or enforced. The FDA still recommends prescribers monitor patients’ absolute neutrophil count to prevent severe neutropenia.